Source: International Congress 2016 – Sarcoidosis
Disease area: Interstitial lung diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Robina K. Coker (London, United Kingdom), Robina K. Coker, William Chang, Nazia Chaudhuri, Sue Copley, Owen Dempsey, Ian Forrest, Michael Gibbons, Ling-Pei Ho, Toby M. Maher, Helen Parfrey, Luca Richeldi, Lisa Spencer, Monica Spiteri. Sarcoidosis in the UK: Insights from the BTS interstitial lung disease registry. Eur Respir J 2016; 48: Suppl. 60, 822

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Epidemiology of IPF in Italy Source: International Congress 2014 – ILDs 6 Year: 2014 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 Lymphangioleiomyomatosis in TOSCA - TuberOus SClerosis registry to increAse disease awareness Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Case presentation: Should we always treat IgG4-related lung disease? Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases Source: International Congress 2016 – Orphan diseases I Year: 2016 Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry Source: International Congress 2014 – ILDs 1 Year: 2014 Clinical findings at initial presentation of IPF patients at a university hospital referral center Source: International Congress 2014 – ILDs 5 Year: 2014 Lung diseases infection and risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients Source: International Congress 2014 – Sarcoidosis Year: 2014 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Aetiological panorama in the diagnosis of interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Burden of lung disease in the UK; findings from the British Lung Foundation’s ’respiratory health of the nation’ project Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016